[
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-1",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#definitiongeneral474060",
    "clean_content": "Definition / general\n\n* Benign, rare tumor of odontogenic origin* Cuboidal to columnar ameloblastic epithelium that forms duct-like structures, epithelial whorls and cribriform architecture; dentinoid deposits, clusters of clear cells and ghost cell keratinization may also be present ([J Oral Maxillofac Pathol 2012;16:272](22923903))"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-2",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#essentialfeatures474061",
    "clean_content": "Essential features\n\n* Adenoid ameloblastomas have a predilection for the posterior mandible ([Head Neck Pathol 2022;16:344](34282559))* Microscopically, adenoid ameloblastomas consist of epithelium resembling conventional ameloblastoma in addition to duct-like structures, epithelial whorls and cribriform architecture* Dentinoid deposits, clusters of clear cells and ghost cell keratinization may also be observed ([J Oral Maxillofac Pathol 2012;16:272](22923903))* Adenoid ameloblastoma can be a challenging and controversial diagnosis as this tumor has features seen in numerous odontogenic tumors (i.e., ameloblastoma, adenomatoid odontogenic tumor, calcifying odontogenic cyst / dentinogenic ghost cell tumor and odontogenic carcinoma with dentinoid)"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-3",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#terminology474062",
    "clean_content": "Terminology\n\n* Adenoid ameloblastoma with dentinoid was proposed by Brannon of the Armed Forces Institute of Pathology in 1994; this terminology has been deemed acceptable by the World Health Organization (WHO) ([Brannon: Adenoid Ameloblastoma With Dentinoid, 1994](https://scholar.google.com/scholar_lookup?title=Adenoid+ameloblastoma+with+dentinoid&author=RB+Brannon&publication_year=1994&))* Described as dentinoameloblastoma by Slabbert et al. in 1992 ([J Oral Pathol Med 1992;21:46](1593496))"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-4",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#icdcoding474063",
    "clean_content": "ICD coding\n\n* ICD-O: [9300/0](https://iris.who.int/bitstream/handle/10665/96612/9789241548496_eng.pdf?sequence=1#page=89) - adenoid ameloblastoma* ICD-10\n    + [D16.4](https://www.icd10data.com/ICD10CM/Codes/C00-D49/D10-D36/D16-/D16.4) - benign neoplasm of skull and face+ [D16.5](https://www.icd10data.com/ICD10CM/Codes/C00-D49/D10-D36/D16-/D16.5) - benign neoplasm of lower jaw bone* ICD-11\n      + [2E83.0 & XH1SV4](https://icd.who.int/browse11/l-m/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f1486607775?data=%7B%22dataType%22%3A%22pc%22%2C%22postcoordinationCodeSet%22%3A%7B%22stemId%22%3A%22http%3A%2F%2Fid.who.int%2Ficd%2Fentity%2F1486607775%22%2C%22axisToValueIds%22%3A%7B%22specificAnatomy%22%3A%5B%7B%22stemId%22%3A%22http%3A%2F%2Fid.who.int%2Ficd%2Fentity%2F92385094%22%7D%5D%7D%7D%7D) - benign osteogenic tumors of bone or articular cartilage of skull or face & ameloblastoma, NOS+ [2E83.1 & XH1SV4](https://icd.who.int/browse11/l-m/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f1037047819?data=%7B%22dataType%22%3A%22pc%22%2C%22postcoordinationCodeSet%22%3A%7B%22stemId%22%3A%22http%3A%2F%2Fid.who.int%2Ficd%2Fentity%2F1037047819%22%2C%22axisToValueIds%22%3A%7B%22histopathology%22%3A%5B%7B%22stemId%22%3A%22http%3A%2F%2Fid.who.int%2Ficd%2Fentity%2F92385094%22%7D%5D%7D%7D%7D) - benign osteogenic tumors of bone or articular cartilage of lower jaw & ameloblastoma, NOS"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-5",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#epidemiology474064",
    "clean_content": "Epidemiology\n\n* Occurrence peaks in the fourth decade, with a slight male predilection (M:F = 1.3:1) and a wide age range of 15 - 82 years ([Head Neck Pathol 2022;16:344](34282559))"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-6",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#sites474065",
    "clean_content": "Sites\n\n* ~64.7% of adenoid ameloblastomas occur in the mandible ([Head Neck Pathol 2022;16:344](34282559))\n  + Posterior gnathic bones are most commonly affected ([Head Neck Pathol 2023;17:688](37540485))"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-7",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Etiology",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#etiology474066",
    "clean_content": "Etiology\n\n* Unknown"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-8",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#clinicalfeatures474067",
    "clean_content": "Clinical features\n\n* Usually an asymptomatic swelling (unless secondarily infected)* Tooth displacement may be present"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-9",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#diagnosis474068",
    "clean_content": "Diagnosis\n\n* Adenoid ameloblastoma may be detected radiographically as an incidental finding or present as a clinical swelling"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-10",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#radiologydescription474069",
    "clean_content": "Radiology description\n\n* 82.4% of adenoid ameloblastomas present exclusively as radiolucent lesions and may be ill defined ([Head Neck Pathol 2022;16:344](34282559))\n  + May also appear as mixed density due to the presence of dentinoid* May be unilocular or multilocular"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-11",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Radiology images",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#radiologyimages474070",
    "clean_content": "Radiology images\n\n*Images hosted on other servers:*  \n\n[![Diffuse periapical radiolucency](https://www.pathologyoutlines.com/thumb/mandiblemaxillaadenoidameloblastomanih01.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424947/figure/F2/)\n\nDiffuse periapical radiolucency"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-12",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#prognosticfactors474071",
    "clean_content": "Prognostic factors\n\n* 45.4% of adenoid ameloblastomas developed at least 1 recurrence following surgical excision ([Head Neck Pathol 2022;16:344](34282559))"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-13",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#casereports474072",
    "clean_content": "Case reports\n\n* 39 year old man with a chief concern of painful, mobile teeth in the right posterior maxilla ([Oral Surg Oral Med Oral Pathol Oral Radiol 2019;128:E53](https://doi.org/10.1016/j.oooo.2019.02.116))* 54 year old woman with asymptomatic radiolucency of the left posterior maxilla ([Oral Maxillofac Surg 2020;24:243](31925581))* 57 year old woman with a well defined, unilocular radiolucency between the roots of the right mandibular premolars without intraoral changes ([Oral Surg Oral Med Oral Pathol Oral Radiol 2022;134:E162](https://doi.org/10.1016/j.oooo.2022.01.436))"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-14",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#treatment474073",
    "clean_content": "Treatment\n\n* Conventional treatment consists of surgical resection as primary therapy ([Oral Surg Oral Med Oral Pathol Oral Radiol 2015;120:368](26297394))\n  + Patients may also receive radiotherapy as adjuvant to prevent recurrence ([Oral Surg Oral Med Oral Pathol Oral Radiol 2015;120:368](26297394))"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-15",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#microscopichistologicdescription474074",
    "clean_content": "Microscopic (histologic) description\n\n* Epithelium resembling conventional ameloblastoma, particularly palisading of cells at peripheries of the tumor nests, with additional duct-like structures and cribriform architecture* Basophilic areas of cellular condensation or morules may be present* Dentinoid deposits, clusters of clear cells and ghost cell keratinization may also be observed ([J Oral Maxillofac Pathol 2012;16:272](22923903))* Mitotic activity may be increased ([Oral Surg Oral Med Oral Pathol Oral Radiol 2019;128:e78](https://doi.org/10.1016/j.oooo.2019.02.196), [Oral Surg Oral Med Oral Pathol Oral Radiol 2015;120:368](26297394))"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-16",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#microscopichistologicimages474075",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Elizabeth Ann Bilodeau, D.M.D., M.D., M.S.Ed.   \n\n[![Epithelial whorls](https://www.pathologyoutlines.com/imgau/mandiblemaxillaadenoidameloblastomaBilodeau01.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillaadenoidameloblastomaBilodeau01.jpg)\n\nEpithelial whorls\n\n[![Cribriform architecture and eosinophilic matrix](https://www.pathologyoutlines.com/imgau/mandiblemaxillaadenoidameloblastomaBilodeau02.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillaadenoidameloblastomaBilodeau02.jpg)\n\nCribriform architecture and eosinophilic matrix\n\n[![Focal ghost cell keratinization](https://www.pathologyoutlines.com/imgau/mandiblemaxillaadenoidameloblastomaBilodeau03.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillaadenoidameloblastomaBilodeau03.jpg)\n\nFocal ghost cell keratinization\n\n[![Dentinoid deposits](https://www.pathologyoutlines.com/imgau/mandiblemaxillaadenoidameloblastomaBilodeau04.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillaadenoidameloblastomaBilodeau04.jpg)\n\nDentinoid deposits\n\n[![Increased mitotic activity](https://www.pathologyoutlines.com/imgau/mandiblemaxillaadenoidameloblastomaBilodeau05.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillaadenoidameloblastomaBilodeau05.jpg)\n\nIncreased mitotic activity\n\n[![Duct-like structures and ghost cell keratinization](https://www.pathologyoutlines.com/imgau/mandiblemaxillaadenoidameloblastomaBilodeau06.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillaadenoidameloblastomaBilodeau06.jpg)\n\nDuct-like structures and ghost cell keratinization"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-17",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#positivestains474076",
    "clean_content": "Positive stains\n\n* [AE1 / AE3](https://www.pathologyoutlines.com/topic/stainsae1ae3.html) ([Oral Surg Oral Med Oral Pathol Oral Radiol 2019;128:e78](https://doi.org/10.1016/j.oooo.2019.02.196))* [Beta catenin](https://www.pathologyoutlines.com/topic/stainsbetacatenin.html) within morules ([Oral Surg Oral Med Oral Pathol Oral Radiol 2019;128:e78](https://doi.org/10.1016/j.oooo.2019.02.196))* [CK5/6](https://www.pathologyoutlines.com/topic/stainsck5and6.html) ([Oral Surg Oral Med Oral Pathol Oral Radiol 2019;128:e78](https://doi.org/10.1016/j.oooo.2019.02.196))* [Ki67](https://www.pathologyoutlines.com/topic/stainski67.html) may have variable expression, with the upper limit being 72.4 plus or minus 24.9 positive cells per high power field ([Oral Surg Oral Med Oral Pathol Oral Radiol 2015;120:368](26297394))* [p63](https://www.pathologyoutlines.com/topic/stainsp63.html) and [p40](https://www.pathologyoutlines.com/topic/stainsp40.html) are positive ([Oral Surg Oral Med Oral Pathol Oral Radiol 2019;128:e78](https://doi.org/10.1016/j.oooo.2019.02.196))* [p16](https://www.pathologyoutlines.com/topic/stainsp16.html) is variable ([Oral Surg Oral Med Oral Pathol Oral Radiol 2015;120:368](26297394), [Oral Surg Oral Med Oral Pathol Oral Radiol 2019;128:e78](https://doi.org/10.1016/j.oooo.2019.02.196))"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-18",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#negativestains474077",
    "clean_content": "Negative stains\n\n* [BRAF V600E](https://www.pathologyoutlines.com/topic/stainsbraf.html)* [CK7](https://www.pathologyoutlines.com/topic/stainsck7.html)* [p53](https://www.pathologyoutlines.com/topic/stainsp53.html)* [SMA](https://www.pathologyoutlines.com/topic/stainsalphasmoothmuscleactin.html)* [SOX10](https://www.pathologyoutlines.com/topic/stainssox10.html)* [S100](https://www.pathologyoutlines.com/topic/stainss100.html)* Reference: [Oral Surg Oral Med Oral Pathol Oral Radiol 2019;128:e78](https://doi.org/10.1016/j.oooo.2019.02.196)"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-19",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#molecularcytogeneticsdescription474078",
    "clean_content": "Molecular / cytogenetics description\n\n* *BRAF* p.V600E mutation (which is observed in other ameloblastomas) in addition to *KRAS* p.G12V and *KRAS* p.G12R mutations (both of which are typical of adenomatoid odontogenic tumors) are absent in adenoid ameloblastomas ([J Oral Pathol Med 2021;50:1067](34549835))* Based on limited data, beta catenin mutations, particularly p.Ser33Cys, p.Gly34Arg and p.Ser37Phe, were observed in 4 of 9 patients ([Mod Pathol 2022;35:1562](35840721))"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-20",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#samplepathologyreport474079",
    "clean_content": "Sample pathology report\n\n* Posterior mandible, right, incisional biopsy:\n  + Adenoid ameloblastoma, 1.5 cm"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-21",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#differentialdiagnosis474080",
    "clean_content": "Differential diagnosis\n\n* [Ameloblastoma](https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblastoma.html):\n  + Columnar cells with palisading, hyperchromatic nuclei of basal cells+ No hard tissue formation is present* [Adenomatoid odontogenic tumor](https://www.pathologyoutlines.com/topic/mandiblemaxillaadenomatoid.html):\n    + Epithelium may appear nodular, trabecular or cribriform with duct-like structures+ Amyloid deposits may be present+ Enclosed in thick capsule; radiographically often well defined and associated with impacted maxillary canines* [Calcifying cystic odontogenic tumor](https://www.pathologyoutlines.com/topic/mandiblemaxillacalcifyingodontogenic.html):\n      + Ameloblastic epithelium and ghost cells+ Lacks whorls, duct-like structures and cribriform architecture* [Dentinogenic ghost cell tumor](https://www.pathologyoutlines.com/topic/mandiblemaxilladentinogenicghost.html):\n        + Ameloblastic-like areas with palisading of basaloid cells+ Admixed ghost cells: anucleate epithelial cells with pale, cleared cytoplasm+ Lacks whorls, duct-like structures and cribriform architecture"
  },
  {
    "id": "adenoid-ameloblastoma_46322_1750166800.txt-22",
    "source_document": "adenoid-ameloblastoma_46322_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaadenoidameloblastoma.html#additionalreferences474081",
    "clean_content": "Additional references\n\n* [WHO Classification of Tumours Editorial Board: Head and Neck Tumours, 5th Edition, 2024](https://www.amazon.com/exec/obidos/ASIN/9283245148/pathologyoutl-20)"
  }
]